High expression of krüppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curatively resected pancreatic adenocarcinoma: From a randomized phase III trial
Shu-Ling Pen, Yan‐Shen Shan, Chin‐Fu Hsiao, Tsang‐Wu Liu, Jen‐Shi Chen, Ching-Liang Ho, Wen-Chi Chou, Ruey‐Kuen Hsieh, Li‐Tzong Chen, Hui-Ju Ch'ang
Topics & Concepts
MedicineGemcitabineChemoradiotherapyInternal medicineOncologyPancreatic ductal adenocarcinomaGrading (engineering)AdjuvantAdenocarcinomaImmunohistochemistryPancreatic cancerRadiation therapyAdjuvant radiotherapyClinical trialBiomarkerRandomized controlled trialGastroenterologyCancerBiochemistryChemistryEngineeringCivil engineeringKruppel-like factors researchTGF-β signaling in diseasesGenetic Syndromes and Imprinting